Umbilical cord blood-derived T regulatory cells to prevent GVHD: Kinetics, toxicity profile, and clinical effect

Blood

Volumn 127, Issue 8, 2016, Pages 1044-1051

  Brunstein, Claudio G ^a   Miller, Jeffrey S ^a   McKenna, David H ^a,b   Hippen, Keli L ^a   DeFor, Todd E ^a,c   Sumstad, Darin ^a   Curtsinger, Julie ^a   Verneris, Michael R ^a   MacMillan, Margaret L ^a   Levine, Bruce L ^d   Riley, James L ^d   June, Carl H ^d   Le, Chap ^a,c   Weisdorf, Daniel J ^a   McGlave, Philip B ^a   Blazar, Bruce R ^a   Wagner, John E ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLUDARABINE; INTERLEUKIN 7 RECEPTOR; MYCOPHENOLATE MOFETIL; RAPAMYCIN; TRANSCRIPTION FACTOR FOXP3;

ADOPTIVE TRANSFER; ADULT; AGED; ARTICLE; CHIMERA; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INCIDENCE; K562 CELL LINE; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; UMBILICAL CORD BLOOD; ADOLESCENT; ADVERSE EFFECTS; CHILD; CLINICAL TRIAL; CORD BLOOD STEM CELL TRANSPLANTATION; FETUS BLOOD; GRAFT VS HOST DISEASE; IMMUNOTHERAPY; KAPLAN MEIER METHOD; KINETICS; MAXIMUM TOLERATED DOSE; MIDDLE AGED; PROCEDURES; PROPORTIONAL HAZARDS MODEL; TRANSPLANTATION; TRANSPLANTATION CONDITIONING; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE-FREE SURVIVAL; FEMALE; FETAL BLOOD; GRAFT VS HOST DISEASE; HUMANS; IMMUNOTHERAPY; INCIDENCE; KAPLAN-MEIER ESTIMATE; KINETICS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION CONDITIONING; YOUNG ADULT;

EID: 84960337895     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-06-653667     Document Type: Article

References (18)

1. Sakaguchi S. Regulatory T cells: history and perspective. Methods Mol Biol. 2011;707:3-17.
2. Shen LS, Wang J, Shen DF, et al. CD4(1)CD25(1)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression. Clin Immunol. 2009; 131(1):109-118.
3. Yu N, Li X, Song W, et al. CD4(1)CD25 (1)CD127 (low/-) T cells: a more specific Treg population in human peripheral blood. Inflammation. 2012;35(6):1773-1780.
4. Brunstein CG, Miller JS, Cao Q, et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood. 2011;117(3): 1061-1070.
5. Brunstein CG, Blazar BR, Miller JS, et al. Adoptive transfer of umbilical cord blood-derived regulatory T cells and early viral reactivation. Biol Blood Marrow Transplant. 2013;19(8):1271-1273.
6. Hippen KL, Merkel SC, Schirm DK, et al. Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity. Sci Transl Med. 2011;3(83): 83ra41.
7. Brunstein CG, Barker JN, Weisdorf DJ, et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood. 2007;110(8): 3064-3070.
8. Simon R, Freidlin B, Rubinstein L, Arbuck SG, Collins J, Christian MC. Accelerated titration designs for phase I clinical trials in oncology. J Natl Cancer Inst. 1997;89(15):1138-1147.
9. McKenna DH, Sumstad DJ, Brunstein CG, et al. cGMP production of umbilical cord blood-derived T-regulatory cells in support of a first in human clinical trial [abstract]. Cytotherapy. 2010; 12(Suppl 1):19.
10. Suhoski MM, Golovina TN, Aqui NA, Tai VC, Varela-Rohena A, Milone MC, et al. Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules. Mol Ther. 2007;15(5):981-988.
11. Golovina TN, Mikheeva T, Suhoski MM, et al. CD28 costimulation is essential for human T regulatory expansion and function. J Immunol. 2008;181(4):2855-2868.
12. McCullagh PN. Generalized Linear Models. 2nd ed. Dordrecht, Netherlands: Chapman and Hall/CRC; 1989.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
14. Lin DY. Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med. 1997;16(8):901-910.
15. Taylor PA, Panoskaltsis-Mortari A, Swedin JM, et al. L-Selectin(hi) but not the L-selectin(lo) CD41251 T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood. 2004; 104(12):3804-3812.
16. Thornton AM, Korty PE, Tran DQ, et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymicderived from peripherally induced Foxp31 T regulatory cells. J Immunol. 2010;184(7): 3433-3441.
17. Duhen T, Duhen R, Lanzavecchia A, Sallusto F, Campbell DJ. Functionally distinct subsets of human FOXP31 Treg cells that phenotypically mirror effector Th cells. Blood. 2012;119(19): 4430-4440.
18. Betts BC, Young JA, Ustun C, Cao Q, Weisdorf DJ. Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary? Biol Blood Marrow Transplant. 2011;17(10):1562-1568.